Company/Estimate
- (SWK)/1.10
- (ENR)/2.22
- (HAL)/.69
- (BDK)/1.03
- (FPL)/.67
- (GLW)/.39
- (SYY)/.42
- (MCD)/.70
- (VZ)/.62
- (TSN)/.04
- (AXP)/.71
- (VMW)/.24
- (PAY)/.37
- (OSG)/.63
Alliance Data Systems Corp. (ADS) tumbled $26.21, or 40 percent, to $39.39. The credit-card processor's acquisition by Blackstone Group LP (BX:US) won't receive approval by the U.S. Comptroller of the Currency, the company said.
Black & Decker Corp. (BDK) lost $5.55, or 7.9 percent, to $64.43. The largest U.S. power-tool maker predicted first-quarter profit of as little as $1.10 a share, saying ``we recognize that the U.S. economy is slowing'' in a statement. Analysts expected $1.46, the average estimate in a Bloomberg survey.
Corning Inc. (GLW) rose $1.14, or 5.1 percent, to $23.51. The biggest maker of glass for flat-panel displays posted a fourth-quarter profit that exceeded analysts' predictions on rising television sales.
Halliburton Co. (HAL): The world's second-largest oilfield-services provider reported more fourth-quarter profit than analysts estimated as clients increased exploration and production spending outside North America. Halliburton rose 2.2 percent to $33.09 on Jan. 25.
Helmerich & Payne Inc. (HP): The contract oil and gas driller may rise as much as 68 percent as it doubles its market share with modern, cost-efficient technology, Barron's reported, citing Cypress Capital Management money manager Richard Arvedlund. Helmerich & Payne rose 7 cents to $35.77 on Jan. 25.
Hovnanian Enterprises Inc. (HOV): Jeffrey Gendell reduced his stake in New Jersey's largest homebuilder to 6.4 percent from 8.8 percent, according to a Securities and Exchange Commission filing. The stock lost 2 cents to $7.29 in regular trading.
Merck & Co. (MRK): Merck and another drugmaker, Schering- Plough Corp. (SGP:US), were subpoenaed by New York Attorney General Andrew Cuomo, who is investigating the marketing of the drug Vytorin and sales of its shares before negative results were made public. On Jan. 25, Merck said its application to sell the cholesterol pill Mevacor without a prescription was rejected by U.S. regulators. Merck shares fell $1.77 to $47.79 in regular trading, and Schering-Plough declined $1.15 to $19.02.
State Street Corp. (STT): The money manager is among many including Franklin Resources Inc. and Janus Capital Group Inc. vying for potentially billions of dollars in fees to manage sovereign wealth investments, the Wall Street Journal reported. State Street stock fell $3.12, or 3.8 percent, to $78.52, Franklin Resources declined 51 cents to $98.39 and Janus Capital shares slid 78 cents to $26.98 on Jan. 25.
WellCare Health Plans Inc. (WCG): The insurer being investigated by the FBI for possible fraud said Todd Farha, chief executive officer of the company, resigned effective March 31. Finance chief Paul Behrens and general counsel Thaddeus Bereday also quit. The stock rose 87 cents to $43.12 on Jan. 25.
Watch MCF, CMO for long breakouts.
Watch BDK, MET, MAN, KCI, EW for short breakdowns.
-MM
